ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.45
+0.86 (3.23%)
Nov 22, 2024, 4:00 PM EST - Market closed

ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $924.99 million. The enterprise value is $642.35 million.

Market Cap 924.99M
Enterprise Value 642.35M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date Nov 13, 2024
Ex-Dividend Date n/a

Share Statistics

AVBP has 33.70 million shares outstanding. The number of shares has increased by 1,230.98% in one year.

Current Share Class 33.70M
Shares Outstanding 33.70M
Shares Change (YoY) +1,230.98%
Shares Change (QoQ) +0.24%
Owned by Insiders (%) 2.65%
Owned by Institutions (%) 47.76%
Float 16.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.33
P/TBV Ratio 3.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 19.28, with a Debt / Equity ratio of 0.00.

Current Ratio 19.28
Quick Ratio 18.69
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.07% and return on invested capital (ROIC) is -26.05%.

Return on Equity (ROE) -36.07%
Return on Assets (ROA) -24.68%
Return on Capital (ROIC) -26.05%
Revenue Per Employee n/a
Profits Per Employee -$2.03M
Employee Count 40
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 28.17
200-Day Moving Average 21.98
Relative Strength Index (RSI) 41.86
Average Volume (20 Days) 145,969

Short Selling Information

The latest short interest is 3.54 million, so 10.49% of the outstanding shares have been sold short.

Short Interest 3.54M
Short Previous Month 3.41M
Short % of Shares Out 10.49%
Short % of Float 22.02%
Short Ratio (days to cover) 10.97

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -93.72M
Pretax Income n/a
Net Income -81.05M
EBITDA n/a
EBIT -93.72M
Earnings Per Share (EPS) -$3.42
Full Income Statement

Balance Sheet

The company has $282.86 million in cash and $213,000 in debt, giving a net cash position of $282.64 million or $8.39 per share.

Cash & Cash Equivalents 282.86M
Total Debt 213,000
Net Cash 282.64M
Net Cash Per Share $8.39
Equity (Book Value) 277.49M
Book Value Per Share 8.24
Working Capital 277.24M
Full Balance Sheet

Cash Flow

Operating Cash Flow -68.97M
Capital Expenditures n/a
Free Cash Flow -68.97M
FCF Per Share -$2.05
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,230.98%
Shareholder Yield -1,230.98%
Earnings Yield -8.76%
FCF Yield -7.46%

Analyst Forecast

The average price target for AVBP is $36.80, which is 34.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target $36.80
Price Target Difference 34.06%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2